INCY Technical Analysis
INCY Technical Analysis Data
As of date:2/6/2023
INCY stock price:84.36
INCY 50 DMA:81.76
INCY 200 DMA:75.92
INCY MACD (200-50):-5.84
INCY RSI:61.78
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)61.78
Extremely
Oversold

Also see:
INCY Market Cap History
INCY Shares Outstanding History
INCY YTD Return

INCY Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree INCY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
INCY Stock Price Chart
Technical Analysis News

Bullish Two Hundred Day Moving Average Cross - VNOM
1 hour, 9 minutes ago


Alpine Immune Sciences Breaks Below 200-Day Moving Average - Notable for ALPN
1 hour, 9 minutes ago


Notable Two Hundred Day Moving Average Cross - NAAS
1 hour, 9 minutes ago


Casella Waste Systems (CWST) Shares Cross Below 200 DMA
1 hour, 23 minutes ago


DTC Makes Notable Cross Below Critical Moving Average
1 hour, 31 minutes ago


HII Makes Bullish Cross Above Critical Moving Average
1 hour, 32 minutes ago


Bullish Two Hundred Day Moving Average Cross - PXI
1 hour, 32 minutes ago


Bullish Two Hundred Day Moving Average Cross - MKP.CA
1 hour, 35 minutes ago


Shares of TAIL Now Oversold
1 hour, 35 minutes ago


Bullish Two Hundred Day Moving Average Cross - POU.CA
1 hour, 35 minutes ago


Bullish Two Hundred Day Moving Average Cross - BRO
1 hour, 35 minutes ago


Enact Holdings Breaks Below 200-Day Moving Average - Notable for ACT
5 hours, 54 minutes ago


RXRX Makes Notable Cross Below Critical Moving Average
5 hours, 57 minutes ago


Zumiez (ZUMZ) Shares Cross Below 200 DMA
5 hours, 58 minutes ago


A-Mark Precious Metals (AMRK) Shares Cross Below 200 DMA
5 hours, 58 minutes ago


More Technical Analysis News

INCY Technical Analysis Charts
INCY Technical AnalysisINCY RSI
About Incyte Corporation
Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. JAKAFI (ruxolitinib) is Co.'s initial product approved by the U.S. Food and Drug Administration for the treatment of adults with intermediate or high-risk myelofibrosis, for the treatment of adults with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea, for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older and for the treatment of chronic GVHD after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.

When researching a stock like Incyte, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from INCY Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for INCY stock — the real life supply and demand for the stock over time — and examines that data in different ways.
Featured Slideshows
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
INCY Technical Analysis Charts
INCY DMAINCY MACD
Video: Technical Analysis
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
INCY Technical Analysis Peers
Incyte (INCY) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

IQV Technical Analysis
ISRG Technical Analysis
JNJ Technical Analysis
LH Technical Analysis
LLY Technical Analysis
MCK Technical Analysis
MDT Technical Analysis
MMM Technical Analysis
MOH Technical Analysis
MRK Technical Analysis
More Healthcare companies »

 

INCY Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2023, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.